SCHEMBL21385367

SCHEMBL21385367

c1ccc(C(=NNc2cc3c4ccccc4ccc3c3ccccc23)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 5/20 0.47
SOS1 Q07889 1/20 0.45
ALDH1A1 P00352 6/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.37
HPGD P15428 1/20 0.37
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP2A6 P11509 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12201496 0.91 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL19844146 0.89 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12225434 0.84 ALDH1A1 (0.39) HPRT1SOS1ALDH1A1SMN1; SMN2LMNA
SCHEMBL10021267 0.80 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL29496057 0.79 CYP3A4 (0.53) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL20152833 0.78 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12315065 0.77 S1PR5 (0.40) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12757681 0.77 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL20200693 0.76 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12758094 0.76 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 HPRT1 18/4885SOS1 101/4885ALDH1A1 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.